The Original Investigation titled “Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial”1 published online May 13, 2021, included an error in the name of one author. The author’s name is Konstantinos-Velios Kamposioras. This article has been corrected online.
Reference
- 1.Hall PS, Swinson D, Cairns DA, et al. ; GO2 Trial Investigators . Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced gastroesophageal cancer: the GO2 phase 3 randomized clinical trial. JAMA Oncol. 2021. Published online May 13, 2021. doi: 10.1001/jamaoncol.2021.0848 [DOI] [PMC free article] [PubMed] [Google Scholar]